Zongbi Yi

Statistics

Publications

Citations

1.1K

H-Index

Active since

2016

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Cancer Hospital of Huanxing Chaoyang District Beijing

National Cancer Center

Sun Yat-sen University Cancer Center

Sun Yat-sen University

Zongbi Yi is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2016–2024

Publications

Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Fei Ma, Qiao Li, Shanshan Chen et al. · Journal of Clinical Oncology · 2017 · 234 citations

Medicine, Oncology, Pharmacology +17

ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

Fei Ma, Wenjie Zhu, Yanfang Guan et al. · Oncotarget · 2016 · 95 citations · Full text

Medicine, Molecular Biology, Oncology +17

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial

Qiao Li, Xiuwen Guan, Shanshan Chen et al. · Clinical Cancer Research · 2019 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +17

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

Fei Ma, Yanfang Guan, Zongbi Yi et al. · International Journal of Cancer · 2019 · 90 citations

Medicine, Molecular Medicine, Oncology +15

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer

Zongbi Yi, Guohua Rong, Yanfang Guan et al. · npj Breast Cancer · 2020 · 74 citations · Full text

Medicine, Molecular Medicine, Oncology +17

1–5 of 25